Debbie Rigby rounds up the latest in research news
The pharmacological treatment for stable COPD is based on the use of inhaled bronchodilators (long-acting muscarinic receptor antagonists and long-acting beta-2 adrenoceptor agonists) and inhaled corticosteroids. This review focuses on the main characteristics of this inhaler combination evaluating the main clinical effects, the patients’ adherence, and the safety. The inhaler combination FF/UMEC/VI has shown a good patient adherence and preference from patients.
Patient Preference and Adherence 2018:12 993–1001
Neuropathic pain is relatively common and often poorly treated. Management options include tricyclic antidepressants or serotonin and noradrenaline reuptake inhibitors in the first instance, followed by pregabalin or gabapentin. Tramadol or topical lidocaine (lignocaine) could be considered as second line. Stronger opioids have been relegated to third line.
Aust Prescr 2018;41:60–3
Eye infections are a common presenting problem in primary care. Patients with eye infections typically present with pain, blurred vision and a red eye. Red eye, conjunctivitis and corneal ulcer/keratitis are discussed in this article. Primary healthcare providers should avoid prescribing topical antibiotics for an eye infection unless the patient has bacterial conjunctivitis. Viral conjunctivitis is common and self-limiting.
Aust Prescr 2018;41:67–72.
A study conducted in the Australian Capital Territory with three general practices has shown patients welcomed improved understanding about their medication, and general practice staff appreciated pharmaceutical advice about patients with chronic conditions. Practice pharmacists were also perceived beneficial by primary healthcare employees surveyed.
Australian journal of Primary Health 2018.